Amsalu Defersha | Clinical Pharmacy Award | Best Researcher Award

Published on by Academic Awards

Dr. Amsalu Defersha | Clinical Pharmacy Award | Best Researcher Award

Dr. Amsalu Defersha, United States International University-Africa, Kenya

Dr. Amsalu Defersha, a renowned Clinical Pharmacist and Lecturer, holds a PhD in Clinical Pharmacy from the University of Nairobi. With extensive experience spanning academia and practice, he has taught at prestigious institutions like Ambo University and University of Gondar. A registered Pharmacist in Kenya and Ethiopia, Dr. Defersha’s expertise lies in Pharmacology and Clinical Pharmacy. He’s received notable awards, including scholarships from the European Union and Addis Ababa University. A prolific researcher, he’s secured grants for studies on cancer treatment outcomes. Dr. Defersha’s publications contribute significantly to the field, enhancing patient care and medication management. 🎓💊📚

 

Publication Profile

Orcid

Google Scholar

🎓 Academic Background

Dr. Amsalu Defersha boasts a rich academic journey, culminating in a PhD in Clinical Pharmacy from the University of Nairobi. Prior to this, he earned a Master of Science in Pharmacology from Addis Ababa University and a Master of Pharmacy in Clinical Pharmacy from the University of Nairobi. His educational foundation began with a Bachelor of Pharmacy from Jimma University, Ethiopia.

🏆 Awards and Recognition:

Dr. Defersha’s academic prowess has been recognized with prestigious awards, including the Intra ACP AFIMEGQ Scholarship from the European Union for his Master of Pharmacy studies in Clinical Pharmacy at the University of Nairobi. Additionally, he received a scholarship for his Master of Science studies in Pharmacology from Addis Ababa University.

🔬 Research Grants

Dr. Defersha has secured notable grants for impactful studies. His 2018 research grant from the United States International University-Africa funded a study on treatment outcomes among adult patients with solid malignancies at Kenyatta National Hospital. In 2022, he received another grant to evaluate drug-related problems and treatment outcomes among patients with gastrointestinal cancers

🔍 Research Focus

Dr. Amsalu Defersha’s research primarily centers around pharmaceutical care and clinical outcomes, particularly in the context of chronic diseases such as diabetes, cancer, and cardiovascular disorders. His work delves into medication adherence, drug therapy problems, and treatment outcomes among ambulatory and hospitalized patients. Through systematic reviews, he also explores healthcare provider knowledge and practices, especially during public health crises like the COVID-19 pandemic. With a focus on improving patient care and medication management, Dr. Defersha’s research contributes significantly to enhancing healthcare delivery and optimizing therapeutic interventions. 📊💊🔬

 

Publication Top Notes 

📚Nonadherence and contributing factors among ambulatory patients with antidiabetic medications in Adama Referral Hospital – Published in Journal of Diabetes Research, 2014 – Cited by 102 times

📚 Evaluation of the anti-diarrheal activity of the leaf extract of Croton macrostachyus Hocsht. ex Del. (Euphorbiaceae) in mice model– Published in BMC Complementary and Alternative Medicine, 2016 – Cited by 80 times

📚 Assessment of drug therapy problems among patients with cervical cancer at Kenyatta National Hospital, Kenya, 2017 – Cited by 37 times

📚 Level of adherence to the dietary recommendation and glycemic control among patients with type 2 diabetes mellitus in Eastern Ethiopia: a cross-sectional study– Published in Diabetes, Metabolic Syndrome and Obesity, 2020 – Cited by 31 times

📚Factors affecting health-related quality of life among prostate cancer patients: a systematic review, 2020 – Cited by 27 times

Surgical site infections and prophylaxis antibiotic use in the surgical ward of public hospital in Western Ethiopia: a hospital-based retrospective cross-sectional study

Medication‐related problems and adverse drug reactions in Ethiopia: A systematic review

Prevalence and risk factors of thromboembolism among patients with coronavirus disease-19: a systematic review and meta-analysis

Knowledge, attitude, and practice of healthcare providers toward novel coronavirus 19 during the first months of the pandemic: a systematic review

Evaluation of the antidiarrheal activity of hydromethanol crude extracts of Ruta chalepensis and Vernonia amygdalina in mice

 

Anand Kumar | Pharmaceutical Science | Best Researcher Award

Published on by Academic Awards

Mr. Anand Kumar | Pharmaceutical Science | Best Researcher Award

Mr. Anand Kumar, Babasaheb Bhimrao Ambedkar University Lucknow, India

🎓 Dr. Anand Kumar is a dedicated researcher and educator with a profound academic background. He holds a Ph.D. in Pharmaceutical Sciences, specializing in areas like Cancer Biology, Muscle Biology, and Sarcopenia. An alumnus of prestigious institutions such as Babasaheb Bhimrao Ambedkar University and Chhatrapti Shahu Ji Maharaj University, Dr. AnandKumar has been honored with fellowships from Indian Council of Medical Research and University Grants Commission. His commitment to advancing pharmaceutical knowledge is underscored by his multiple qualifications and extensive research experience. With a passion for understanding and combating diseases, he represents a beacon of excellence in the field. 🏅

Publication Profile:

Orcid

Google Scholar

Education Qualifications:

🎓 Dr. AnandKumar’s educational journey is marked by a series of impressive accomplishments and a steadfast pursuit of excellence in pharmaceutical sciences. His academic odyssey began with an Intermediate degree in Physics, Chemistry, and Maths from the UP Board, where he attained a commendable first-class score. Venturing further into the realm of pharmacy, he obtained a D. Pharm from Sarojini Naidu Medical College, Agra, demonstrating his early dedication to the field. Undeterred by challenges, he pursued a B. Pharm from Chhatrapti Shahu Ji Maharaj University, Kanpur, and later, an M. Pharm in Pharmacology from Babasaheb Bhimrao Ambedkar University, Lucknow, where he consistently achieved first-class distinctions.His academic journey culminated in a significant milestone with a Ph.D. in Pharmaceutical Sciences from the same institution, where his thesis was submitted in July 2023. Dr. AnandKumar’s relentless pursuit of knowledge and his commitment to academic excellence are evident in his consistent academic achievements. Through his rigorous academic training, he has honed his expertise in areas such as pharmacology and pharmaceutical sciences, paving the way for impactful contributions to the field. Dr. AnandKumar’s educational trajectory exemplifies resilience, dedication, and a profound passion for advancing pharmaceutical research and practice. 🌟

Honors, Recognition, and Awards:

🏅 Dr. AnandKumar’s contributions to pharmaceutical research have been recognized through prestigious honors and awards. In 2022, he was bestowed with the Indian Council of Medical Research (ICMR) Senior Research Fellowship (SRF) by the Ministry of Health and Family Welfare, Government of India, acknowledging his exceptional research prowess. Prior to this, he received the PGSPROF Fellowship from the University Grants Commission (UGC) between 2016 and 2018, further affirming his dedication to academic excellence. Additionally, Dr. AnandKumar’s exemplary performance is underscored by his remarkable achievement of qualifying the Graduate Pharmacy Aptitude Test (GPAT) five times between 2017 and 2023, highlighting his commitment to continuous learning and proficiency in pharmaceutical sciences. 🌟

Professional Experience:

👨‍🏫 Dr. AnandKumar’s professional journey includes both teaching and research experiences, shaping him into a well-rounded pharmaceutical scientist. His teaching tenure spans six months, during which he imparted knowledge and mentored students in various aspects of pharmacy. Complementing his role in academia, Dr. AnandKumar has amassed valuable research experience in diverse domains. Through his engagement in research, he has delved into intricate subjects such as Cancer Biology, Muscle Biology, and Sarcopenia, contributing significantly to the advancement of pharmaceutical sciences. His dual expertise in teaching and research reflects his commitment to academic excellence and his passion for pushing the boundaries of scientific inquiry. 📚🔬

Research Focus:

🔬 Dr. Anand Kumar’s research focus encompasses a broad spectrum of pharmaceutical sciences, with a particular emphasis on combating various aspects of muscle biology-related disorders. His work delves into elucidating mechanisms underlying skeletal muscle wasting conditions such as sarcopenia, diabetic muscle atrophy, and muscle damage induced by diverse factors. Through innovative approaches including pharmacological interventions and targeted drug delivery systems, he aims to mitigate muscle wasting and associated inflammatory responses. Dr. AnandKumar’s multidisciplinary research endeavors, as evidenced by his publications, contribute significantly to understanding and addressing the complexities of muscle-related pathologies, paving the way for novel therapeutic strategies in the field. 🌟

Publication Top Notes:

Novel synergistic approach: tazarotene-calcipotriol-loaded-PVA/PVP-nanofibers incorporated in hydrogel film for management and treatment of psoriasis

Azilsartan Ameliorates Skeletal Muscle Wasting in High Fat Diet (HFD)-induced Sarcopenic Obesity in Rats via Activating Akt Signalling Pathway

Salbutamol ameliorates skeletal muscle wasting and inflammatory markers in streptozotocin (STZ)-induced diabetic rats

Vinpocetine mitigates DMH-induce pre-neoplastic colon damage in rats through inhibition of pro-inflammatory cytokines

Salbutamol Attenuates Diabetic Skeletal Muscle Atrophy by Reducing Oxidative Stress, Myostatin/GDF-8, and Pro-Inflammatory Cytokines in Rats

Atenolol Ameliorates Skeletal Muscle Atrophy and Oxidative Stress Induced by Cast Immobilization in Rats

Evaluation Of Azilsartan Transdermal Hydrogel In Volumetric Muscle Loss Injury In A Rat Model

Investigating the Role of Angiotensin Receptor Blockers (ARBs) In High Fat Diet-Induced Sarcopenic Rats Associated Muscle Wasting

Pentapeptide cRGDfK-Surface Engineered Nanostructured Lipid Carriers as an Efficient Tool for Targeted Delivery of Tyrosine Kinase Inhibitor for Battling Hepatocellular Carcinoma